Home/ Supplements/ Vitamin K/ K-2 MK-7 Raspberry

K-2 MK-7 Raspberry

product on market Tablet or Pill KAL Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · grounded in 1 source · methodology

Vitamin K2 as MK-7 is researched for its role in supporting bone health and cardiovascular function by regulating calcium deposition. There is strong evidence regarding its ability to activate proteins that direct calcium into bones and away from arteries. This ingredient profile is generally considered safe for most users.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for K-2 MK-7 Raspberry
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Tablet(s)
Serving Size
60
Servings
Vitamin
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

100 mcg (83% DV)
Within RDA (0.8× RDA) 275 studies (A:9, B:175)

Other Ingredients

Mannitol Starch Complex Maltodextrin Raspberry Flavor, Natural Other Natural Flavors Cellulose Citric Acid Beet Juice, Powder Stevia Leaf Extract Magnesium Stearate Silica Malic Acid
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

1 Daily

Directions: Dissolve one ActivMelt micro tablet on the tongue daily. Use only as directed.

Warnings & Precautions

Warning: Do not use if safety seal is broken or missing. Keep your licensed health care practitioner informed when using this product.

Keep out of reach of children.

If you are taking blood-thinning (anticoagulant) medications, use this product only under the direction of your doctor.

Formulation Notes

Bone health support ActivMelt Instant Dissolve

Raspberry Natural flavor

Discussion: KAL K-2 MK-7 ActivMelt micro tablets melt quickly in the mouth and are designed for optimal absorption in the body. Studies suggest MK-7 lasts longer in the body than other forms of vitamin K.

Each mirco tablet provides Vitamin K-2 in the optimized MK-7 form.

Vegan, Gluten free, lactose free.

Vegan, Gluten free, lactose free.

Additional Information

Store in a cool, dry place.

Metadata

Product Details

UPC / SKU0 21245 64684 6
DSLD Entry Date2025-02-23
Product TypeVitamin
FormTablet or Pill
BrandKAL
DSLD ID322915
Data Updated2026-04-11
Research

Research Evidence

332
Research Sources
59
Avg Quality
220
Meta Analysis
56
Systematic Review
30
Rct
16
Clinical Trial
3
Guideline
3
Regulatory Source
1
Narrative Review
1
Other
1
Openfda Safety
A Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Antiplatelet agents and anticoagulants for hypertension
Systematic Review The Cochrane database of systematic reviews 2022 PubMed DOI
A Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
A Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
View all evidence for Vitamin K →
Compare

Similar Products

View all Vitamin K products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.